To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A multi-center, randomized, double-blind, comparative study to evaluate the clinical efficacy and safety of QL1206 and Xgeva® in patients with bone metastases from solid tumors.
Epistemonikos ID: b4590972d946938c90039c4577fa9e5be6b53a5a
First added on: May 07, 2024